scispace - formally typeset
D

David Cameron

Researcher at University of Oslo

Publications -  1765
Citations -  141776

David Cameron is an academic researcher from University of Oslo. The author has contributed to research in topics: Large Hadron Collider & Breast cancer. The author has an hindex of 154, co-authored 1586 publications receiving 126067 citations. Previous affiliations of David Cameron include Universidade Nova de Lisboa & Cameron International.

Papers
More filters

Combined search for the Standard Model Higgs boson using up to 4.9 fb[superscript −1] of pp collision data at √s = 7 TeV with the ATLAS detector at the LHC

Georges Aad, +3037 more
Journal ArticleDOI

Identification of molecular apocrine breast tumours by microarray analysis

TL;DR: The identification of a group of breast tumours with increased androgen signalling and a 'molecular apocrine' gene expression profile is reported, suggesting that molecular apocrine tumours represent 8–14% of tumours in four published breast cancer studies.
Journal ArticleDOI

Aluminum-doped zinc oxide transparent conductors deposited by the sol-gel process

TL;DR: In this paper, thin films of transparent conducting aluminum-doped ZnO have been deposited using a sol-gel process and the dependence of electrical characteristics upon aluminum concentration in the films and upon post-deposition heat treatment in vacuum was examined.
Journal ArticleDOI

Measurement of the Z/γ* boson transverse momentum distribution in pp collisions at √s = 7 TeV with the ATLAS detector

Georges Aad, +2914 more
TL;DR: In this paper, a measurement of the Z/gamma* boson transverse momentum spectrum using ATLAS proton-proton collision data at a centre-of-mass energy of root s = 7TeV at the LHC is described.
Journal ArticleDOI

The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer

TL;DR: These data confirm the value of AMH concentration as an early indicator of ovarian ageing including assessment of chemotherapy-induced ovarian follicle loss and may be useful for the comparison of ovarian toxicity of different chemotherapy regimens.